Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Psychedelic / LSD
Psychedelic

LSD

(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

LSD is an extremely potent hallucinogen that alters perception for many hours; its dangers are psychological — bad trips, impaired judgment, and rare lasting effects — not overdose.

Overview

LSD (lysergic acid diethylamide) is one of the most potent mind-altering substances known, active at microgram doses. First synthesized in 1938 and famous from the 1960s, it is usually sold as drops on small squares of blotter paper, as tiny tablets ("microdots"), or in liquid form. It produces profound changes in perception, mood, and thought — "trips" — that typically begin within 20 to 90 minutes and can last 12 hours or more. LSD is not addictive the way opioids or stimulants are, and it rarely causes fatal poisoning, but its effects are intense and unpredictable, and the main risks are psychological: frightening experiences, impaired judgment that can lead to accidents, and, in a small number of people, lasting perceptual or psychiatric effects. There is renewed scientific interest in psychedelics' therapeutic potential, but that research happens in tightly controlled medical settings, not the unregulated market.

Source: NIDA; PubChem CID 5761

Chemistry & mechanism of action

LSD acts mainly on serotonin signaling, binding strongly to the 5-HT2A receptor in regions of the brain involved in perception, mood, and cognition. By altering this serotonin activity, LSD disrupts the brain's normal filtering and integration of sensory information, producing the visual distortions, altered sense of time, and shifts in thought and emotion that characterize a trip. Because the body quickly builds tolerance — the same dose has much less effect over consecutive days — taking more to recapture the effect is both ineffective and dangerous. The drug does not produce the compulsive, withdrawal-driven use seen with physically addictive drugs, but psychological reliance and problematic use can still occur.

Source: NIDA; PubChem CID 5761

Effects

An LSD experience varies enormously with dose, the person's mindset, and their surroundings. Common effects include vivid visual distortions (intensified colors, moving or geometric patterns), a blurring of the senses, an altered sense of time and self, and powerful emotional shifts that can swing between euphoria and anxiety. Physical effects include dilated pupils, raised heart rate and blood pressure, sweating, dizziness, and loss of appetite. A difficult experience — a "bad trip" — can involve intense fear, paranoia, panic, and distressing thoughts, and impaired judgment during a trip can lead to dangerous behavior or accidents. Effects can persist for many hours, and some people feel emotionally drained afterward.

Source: NIDA

Risks & harms

LSD's risks are overwhelmingly psychological rather than toxic — fatal overdose from LSD itself is extraordinarily rare. The most common acute danger is a bad trip: overwhelming fear, paranoia, or panic that, combined with impaired judgment and an altered sense of reality, can lead to accidents or risky behavior. People with a personal or family history of psychosis or serious mental illness face a higher risk of triggering a lasting psychiatric reaction. Two rare but recognized long-term effects are persistent psychosis and hallucinogen persisting perception disorder (HPPD), in which visual disturbances or "flashbacks" recur after the drug has worn off. Because there is no quality control in the illicit market, the dose on a given blotter is unknown, and substances sold as LSD are sometimes other, more dangerous chemicals (such as certain NBOMe compounds) that can be toxic. There is no medication that reverses LSD; a difficult experience is managed with calm reassurance and a safe environment, and severe agitation, injury, or medical symptoms warrant emergency care. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use or mental-health support the SAMHSA National Helpline is 1-800-662-4357.

Source: NIDA; SAMHSA

Subjective effects

heightened sensory awareness, visual distortion (size/shape/color), "hearing colors," intensified emotions, mood swings, time distortion, depersonalization

Onset

30–60 min

Duration

10–12 hr

After-effects

fatigue/anxiety/depression 12–24 hr

Harmful effects

"bad trip" (anxiety/panic/confusion/combative); dilated pupils, raised temp/HR/BP, sweating, tremors

Medicinal use

none in US

Prevalence

NFLIS >51,000 reports since 1997 (peak 4,865 in 2020 → 1,588 in 2024); NSDUH ~30.9M lifetime (2024)

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With psychedelics, fear and confusion are usually temporary. Change your surroundings — calmer light, quiet music, a trusted person — and remind yourself it will lift as the drug wears off.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamidePubChem PUG-REST · retrieved 2026-06-18
SMILES
CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)CPubChem PUG-REST · retrieved 2026-06-18
InChIKey
VAYOSLLFUXYJDT-RDTXWAMCSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
acid, tabs, Lysergide, LYSERGIC ACID DIETHYLAMIDE, D-Lsd, N,N-Diethyllysergamide, Lysergsaeurediaethylamid, N,N-Diethyl-D-lysergamide, Lysergaure diethylamid, LSD-25, LSD 25, LisergidePubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index